Aug 4 2015
VuCOMP, Inc., leading developer of advanced computer vision systems for the detection of breast cancer, today announced that it will be showcasing its portfolio of cutting-edge imaging products at the 20th Annual Mammography in Santa Fe: Music, Mammograms, and Mountains, August 3-7, 2015. The meeting attracts breast imaging professionals from around the country.
VuCOMP will be highlighting the latest enhancements to the M-Vu®System, as well as a works-in-progress CAD solution for 3D breast tomosynthesis.
“VuCOMP is pleased to share the latest features of our product line, as well as share advancements on our works-in-progress CAD for breast tomosynthesis solution,” said Jim Pike, President and CTO of VuCOMP.
M-Vu CAD for mammography is the first mammography CAD proven effective in an FDA-approved reader study. The latest advancements provide radiologists with a substantial reduction in false positive marks and a lower false positive rate while improving sensitivity.
In addition, 3D tomosynthesis has continued to gain widespread acceptance, and with that comes the need for a CAD solution specifically designed to analyze the vast amount of information that tomosynthesis provides. VuCOMP engineers have been working diligently on a cutting-edge solution that is designed to identify regions of interest that are consistent with breast cancer. Ultimately, providing the radiologist with another tool precisely designed for 3D tomosynthesis.